Cerity Partners OCIO’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.6M Buy
10,233
+1,001
+11% +$144K 0.05% 186
2022
Q3
$1.13M Buy
9,232
+1,083
+13% +$143K 0.04% 213
2022
Q2
$1.08M Buy
8,149
+1,296
+19% +$177K 0.04% 205
2022
Q1
$938K Buy
6,853
+596
+10% +$83.1K 0.03% 245
2021
Q4
$1.08M Buy
6,257
+257
+4% +$39.1K 0.03% 212
2021
Q3
$872K Sell
6,000
-11
-0.2% -$1.61K 0.03% 230
2021
Q2
$793K Buy
6,011
+70
+1% +$9.16K 0.03% 242
2021
Q1
$762K Buy
5,941
+182
+3% +$22.4K 0.03% 225
2020
Q4
$686K Sell
5,759
-68
-1% -$8.29K 0.03% 213
2020
Q3
$667K Sell
5,827
-36
-0.6% -$4.25K 0.03% 198
2020
Q2
$668K Buy
5,863
+12
+0.2% +$1.27K 0.03% 195
2020
Q1
$470K Sell
5,851
-1,487
-20% -$154K 0.03% 199
2019
Q4
$818K Sell
7,338
-2,406
-25% -$251K 0.04% 179
2019
Q3
$1.04M Buy
9,744
+46
+0.5% +$4.72K 0.05% 145
2019
Q2
$987K Buy
9,698
+294
+3% +$28.3K 0.05% 138
2019
Q1
$846K Buy
9,404
+1,183
+14% +$103K 0.05% 147
2018
Q4
$685K Buy
8,221
+385
+5% +$36.1K 0.04% 164
2018
Q3
$846K Sell
7,836
-167
-2% -$18.3K 0.05% 146
2018
Q2
$880K Sell
8,003
-97
-1% -$10.1K 0.06% 131
2018
Q1
$812K Buy
+8,100
New +$830K 0.05% 133

Other funds holding DGX

Cerity Partners OCIO's DGX Position: Q4 2022 in Review

Cerity Partners OCIO increased its Quest Diagnostics (DGX) stake by 11% in Q4 2022, buying an estimated $144K and bringing the position to 10,233 shares worth $1.6M. The position accounts for 0.05% of the portfolio, ranked #186.

Cerity Partners OCIO first reported a position in DGX in Q1 2018 and has held it in 20 quarters since. 879 funds tracked by Wall St. Rank hold DGX as of Q4 2022.

  • Cerity Partners OCIO held 10,233 shares of Quest Diagnostics worth $1.6M as of Q4 2022.
  • Cerity Partners OCIO bought 1,001 Quest Diagnostics shares in Q4 2022, an estimated $144K.
  • Quest Diagnostics made up 0.05% of Cerity Partners OCIO's portfolio in Q4 2022, its #186 holding.
  • Cerity Partners OCIO first reported a position in Quest Diagnostics in Q1 2018 and has held it in 20 quarters since.
  • 879 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2022.

Based on Cerity Partners OCIO's 13F filing for Q4 2022, filed 2 Feb 2023.